ALIENCULTIST.COM
RESTRICTED INDEX // PUBLIC ACCESS
← HEALTH & MEDICINE FILES

FILE A42-HM-024 // HEALTH & MEDICINE

COVID-19 PCR Tests and “All Positives Are False”

ASSESSMENT: PCR limitations are real; universal-fraud claim is not.

The claim and its context

PCR can detect viral genetic material after infectiousness declines, and false results occur. Those limitations do not mean every positive was false or case data were fabricated. A valid claim must identify the assay, sampling conditions, and false-positive rate.

PCR became a central diagnostic method in 2020. Assays used different thresholds and procedures; discussion often confused cycle thresholds with standardized viral load. Testing policies changed over time, so case counts are not directly comparable without context.

What is documented

PCR detects nucleic acid, not necessarily live virus. Timing, symptoms, sample quality, and clinical context matter. No evidence supports a coordinated fabrication of all positives; infections were corroborated by hospitalizations, sequencing, and mortality data.

Clinical and epidemiological evidence

Validation studies show high analytical specificity for validated assays, though sampling affects performance. Viral-culture studies show PCR positivity can persist beyond peak infectiousness. This matters for isolation decisions but does not invalidate diagnosis.

Contrary evidence and genuine uncertainty

Thresholds differ across platforms, and early testing capacity varied. Case counts therefore are imperfect measures of incidence. These valid limitations are distinct from evidence that PCR testing itself was fraudulent.

Calibrated assessment

The universal false-positive claim conflicts with converging laboratory and epidemiological evidence. PCR is powerful but imperfect; responsible interpretation uses its characteristics and clinical context.

A responsible evidence test

Check assay validation, timing, sample quality, and corroborating evidence. Compare results with sequencing, hospitalization, and serology when appropriate. Diagnosis and treatment questions belong with a qualified clinician.

Source notes and limitations

  1. WHO — COVID-19 diagnostic test guidanceEarly guidance explains limits; does not say PCR is invalid.
  2. FDA — COVID-19 testing basicsTest performance depends on product and sampling.
  3. Cevik et al. — Viral load, shedding, and infectiousness reviewHeterogeneous early-pandemic studies; PCR positivity is not identical to infectiousness.